Y-mAbs Therapeutics
YMAB
#8047
Rank
NZ$0.36 B
Marketcap
$8.12
Share price
-2.58%
Change (1 day)
-66.13%
Change (1 year)

Earnings for Y-mAbs Therapeutics (YMAB)

Earnings in 2024 (TTM): -NZ$51.67 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's current earnings are NZ$87.68 Million. a decrease over its 2023 earnings that were of -NZ$45.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Y-mAbs Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$55.81 Million21.54%
2023 -NZ$45.92 Million-72.92%
2022 -NZ$0.17 Billion77.47%
2021 -NZ$95.55 Million-55.46%
2020 -NZ$0.22 Billion44.49%
2019 -NZ$0.15 Billion92.01%
2018 -NZ$77.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.26 Billion 357.98%๐Ÿ‡บ๐Ÿ‡ธ USA